metoprolol tartrate 50 MG as metoprolol succinate 47.5 MG Oral Tablet
INDICATIONS AND USAGE Hypertension Metoprolol Tartrate Tablets USP are indicated for the treatment of Hypertension. They may be used alone or in combination with other antihypertensive agents. Angina Pectoris Metoprolol Tartrate Tablets USP are indicated in the long-term treatment of Angina Pectoris. Myocardial Infarction Metoprolol Tartrate Tablets USP are indicated in the treatment of hemodynamically stable patients with definite or suspected acute Myocardial Infarction to reduce cardiovascular mortality when used alone or in conjunction with intravenous metoprolol tartrate. Oral metoprolol tartrate therapy can be initiated after intravenous metoprolol tartrate therapy or, alternatively, oral treatment can begin within 3 to 10 days of the acute event (see DOSAGE AND ADMINISTRATION , CONTRAINDICATIONS , and WARNINGS ).
Teva Pharmaceuticals USA Inc
ROUND PINK 93 733
93 733 ROUND PINK
Related Pills
Lofibra Fenofibrate 160 MG Oral Tablet Lofibra
Teva Select Brands
Lofibra Fenofibrate 160 MG Oral Tablet Lofibra
Teva Select Brands
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED Metoprolol Tartrate Tablets USP are available as follows: 50 mg: pink, round, biconvex, film coated tablets, scored in half on one side with the numbers "93" and "733" on each side of the score. plain on the other side. They are packaged in bottles of 100 and 1000 tablets. 100 mg: Mottled blue, round, biconvex, film coated tablets, scored in half on one side with the numbers "93" and "734" on each side of the score. plain on the other side. They are packaged in bottles of 100 and 1000 tablets. Store at 20 o to 25 o C (68 o to 77 o F) [See USP Controlled Room Temperature]. Protect from moisture and heat. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. To report SUSPECTED ADVERSE REACTIONS, contact TEVA USA, PHARMACOVIGILANCE at 1-888-838-2872, X6351 or drug.safety@tevapharm.com; or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. Manufactured In India By: EMCURE PHARMACEUTICALS LTD. Hinjwadi, Pune, India Manufactured For: TEVA PHARMACEUTICALS USA Sellersville, PA 18960 Rev. M 3/2013
More pills like ROUND 93 733